Beta Finch

Beta Finch - Pharma & Biotech - EN

Business EN ↓ 39 episodes

Leading pharmaceutical and biotechnology companies. AI-powered earnings call analysis for Pharma & Biotech (PHARMA). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.

Be sure to visit the podcast's website and support the creator: betafinch.com

Author

Beta Finch

Category

Business

Podcast website

betafinch.com

Latest episode

Nov 6, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Zoetis Q3 2026 Earnings Analysis 06.11.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Zoetis, ticker ZTS, and their third quarter 2026 results, which came out this morning. **JORDAN:** Lots to unpack here — derm wars, screwworms, and a guy named Jay on his very first earnings call....

Pfizer Q3 2026 Earnings Analysis 04.11.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Pfizer's third quarter 2026 results, reported on November 3rd. And Alex, there's actually a leadership headline buried in here too. ALEX: There is, we'll get to that....

Vertex Pharmaceuticals Q3 2026 Earnings Analysis 03.11.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Vertex Pharmaceuticals' third quarter 2026 results, and this one is packed with news. I'm Alex. **JORDAN:** And I'm Jordan. Vertex is quietly transforming from a cystic fibrosis company into somet...

AbbVie Q3 2026 Earnings Analysis 31.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, joined as always by Jordan, and today we're digging into AbbVie's third quarter 2026 results — and folks, this is another quarter where the raised-guidance train just keeps rolling. **JORDAN:** It really does....

Regeneron Q3 2026 Earnings Analysis 30.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown, where we turn dense earnings calls into conversations you'd actually want to have with a friend. I'm Alex. **JORDAN:** And I'm Jordan. Alex, we've got a big one today. **ALEX:** We really do — Regeneron, ticker REGN, rep...

Gilead Sciences Q3 2026 Earnings Analysis 30.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Gilead Sciences' third quarter 2026 results, and folks, this is a big one. But before we get into the numbers, just a quick note: this podcast is AI-generated content for educational and entertain...

Merck Q3 2026 Earnings Analysis 29.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Merck's third quarter 2026 results, reported this past Thursday. **ALEX:** Before we get into it — quick disclaimer. This podcast is AI-generated content for...

Eli Lilly Q3 2026 Earnings Analysis 29.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, joined as always by Jordan, and today we're digging into Eli Lilly's Q3 2026 results — and folks, this is a big one. **JORDAN:** Huge one. Stock popped over 6.5% on the news. **ALEX:** It really did. But before...

Bristol-Myers Squibb Q3 2026 Earnings Analysis 29.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense earnings calls into conversations you'd actually want to listen to. I'm Alex. **JORDAN:** And I'm Jordan. Today we're digging into Bristol Myers Squibb's third quarter 2026 results, reported this past...

Johnson & Johnson Q3 2026 Earnings Analysis 15.10.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) , INCOME ( https://betafinch.com/groups/INCOME) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're diving into Johnson & Johnson's third quarter 2026 results, reported Tuesday. Before we get going, a quick note — this pod...

Zoetis Q2 2026 Earnings Analysis 29.08.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the numbers and the noise from corporate earnings calls and turn them into something you can actually digest. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Zoetis, ticker ZTS, the animal health gian...

Vertex Pharmaceuticals Q2 2026 Earnings Analysis 29.08.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Vertex Pharmaceuticals' second quarter 2026 results — and there's a lot going on: strong numbers, a major acquisition, and pipeline news across four disease areas. Before we get into it, quick disclai...

Pfizer Q2 2026 Earnings Analysis 29.08.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Pfizer's second quarter 2026 results, and there's a lot to unpack — from a CFO transition to some really important pipeline news. Before we get into it, quick disclaimer: this podcast is AI-generated...

Merck Q2 2026 Earnings Analysis 29.08.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── Welcome to Beta Finch, your AI-powered earnings breakdown for the news that's moving your portfolio. ALEX: Hey everyone, welcome back to Beta Finch! I'm Alex, here with Jordan as always, and today we're digging into Merck's second quarter 2026 numbers. Before we get into it — quick discla...

Eli Lilly Q2 2026 Earnings Analysis 29.08.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Eli Lilly's Q2 2026 results, and Jordan, I'll just say it up front — this was a big one. JORDAN: Big is an understatement. But before we get into the numbers, our standard reminder: this podcast is A...

Gilead Sciences Q2 2026 Earnings Analysis 29.08.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're diving into Gilead Sciences' second quarter 2026 results — and Jordan, this is a big one. JORDAN: It really is. Big numbers, big acquisitions, big pipeline news. ALEX: Before we get into it, quick disclaimer: thi...

AbbVie Q2 2026 Earnings Analysis 31.07.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into AbbVie's second quarter 2026 results, and this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do yo...

Bristol-Myers Squibb Q2 2026 Earnings Analysis 31.07.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Bristol Myers Squibb's second quarter 2026 results, reported Thursday morning. Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes...

Regeneron Q2 2026 Earnings Analysis 31.07.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! Today we're digging into Regeneron's second quarter 2026 results, and Jordan, this was a big one. JORDAN: A really strong quarter across the board. But first, the standard note — this podcast is AI-generated content for educ...

Johnson & Johnson Q2 2026 Earnings Analysis 15.07.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) , INCOME ( https://betafinch.com/groups/INCOME) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Johnson & Johnson's second quarter 2026 results, and Jordan, there's a lot to unpack here. JORDAN: There really is. But first, the fine print — this po...

Gilead Sciences Q1 2026 Earnings Analysis 08.05.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── **Beta Finch Podcast Script - Gilead Q1 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Gilead Sciences' first quarter 2026 results - and wow, what a quarter this was...

Zoetis Q1 2026 Earnings Analysis 07.05.2026

More earnings analysis: https://betafinch.com Groups: PHARMA ( https://betafinch.com/groups/PHARMA) ────────── # Beta Finch Podcast Script: Zoetis Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really happening in the market. I'm Alex. **JORDAN:** And I'm Jordan. Before we dig in, this pod...

Pfizer Q1 2026 Earnings Analysis 05.05.2026

# Beta Finch Podcast Script: Pfizer Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the latest corporate results. I'm Alex, and joining me as always is Jordan. Today we're unpacking Pfizer's Q1 2026 earnings call, and folks, there's quite a bit to unpack here. Before we dive in, I need to mention that this podcast is AI-generated content...

Vertex Pharmaceuticals Q1 2026 Earnings Analysis 05.05.2026

**Beta Finch Podcast Script** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Vertex Pharmaceuticals' Q1 2026 earnings call - and wow, Jordan, this was packed with updates. JORDAN: Absolutely, Alex. But before we jump in, let me get our mandatory...

Merck Q1 2026 Earnings Analysis 30.04.2026

# Beta Finch Podcast Script: Merck Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Merck's Q1 2026 results, and wow - there's a lot to unpack here. **JORDAN:** That's right, Alex. And before we jump in, I need to share our standard disclaimer. This podcast is AI-generated content for educati...

Listen to the Beta Finch - Pharma & Biotech - EN podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.